Jan 16, 2026 Your skin looks worse
Motor symptom severity, as assessed by the Movement Disorder Society-Unified Parkinsons Disease Rating Scale Part III (MDS-UPDRS III), is directly associated with TNF- levels, with higher scores corresponding to increased serum cytokine concentrations [185]
KY19382 clinical development CK Regeon, the company founded by Professor Choi, is developing KY19382 as a pharmaceutical product
Injection site reactions : Where injectable formulations are used, there is an increased risk of localised reactions, particularly if products are sourced from unsterile or unregulated suppliers
Duarte J, Andriambeloson E, Diebolt M, Andriantsitohaina R